Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.09
Delayed Data
As of 9:46am ET
 +0.05 / +4.81%
Today’s Change
0.64
Today|||52-Week Range
1.97
-22.70%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.04
Today’s open1.09
Day’s range1.08 - 1.10
Volume3,580
Average volume (3 months)27,362
Market cap$14.3M
Dividend yield--
Data as of 9:46am ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.91

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...-0.13-3.37%
ATOSAtossa Genetics Inc+0.00+0.21%
CYANCyanotech Corp+0.11+2.72%
EVOKEvoke Pharma Inc+0.01+0.61%
Data as of 1:52pm ET, 08/24/2016

Financials

Last reporting dateMarch 17, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers

Search for Jobs